West Nile Virus

FDA Approves Gen-Probe's TIGRIS Instrument to Screen Donated Blood for West Nile Virus

Published in TB and Outbreaks Week, March 20th, 2007

Gen-Probe Incorporated (NASDAQ:GPRO) announced that the U.S. Food and Drug Administration (FDA) has approved the Company's PROCLEIX(R) TIGRIS(R) System, the first fully automated molecular diagnostics instrument, to screen donated blood, organs and tissues for West Nile virus (WNV) using the PROCLEIX WNV Assay.

"FDA approval of our unique PROCLEIX TIGRIS System for West Nile virus testing is a major milestone for Gen-Probe and a significant advance for blood centers nationwide," said Henry L. Nordhoff, chairman, president and chief executive officer of Gen-Probe. "The PROCLEIX TIGRIS System is the only fully automated, high-throughput testing platform for molecular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2007-03-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry